Uncle Sam Is Buying Into Quantum Computing Stocks. Should You?

The U.S. government invested just over $2 billion across nine quantum computing companies, boosting IBM, IonQ, D-Wave, and Rigetti shares, but the article argues the pure plays remain highly speculative. IonQ, Rigetti, and D-Wave are still burning cash, with Q1 2026 adjusted EBITDA losses of $96.8 million, $14.7 million, and $32.8 million respectively, while IBM posted $4 billion of adjusted EBITDA on $15.9 billion of revenue. Valuations are extreme for the pure plays, with P/S ratios of 163 for IonQ, 768 for D-Wave, and above 800 for Rigetti, making IBM the only comparatively sensible entry point.

Analysis

The market is treating government validation as if it were product-market fit, but that’s a category error. In quantum, policy capital mainly extends runway and compresses perceived funding risk; it does not solve the core commercialization problem, which remains a long-dated engineering bottleneck. That means the immediate beneficiaries are likely not the pure plays themselves, but adjacent suppliers, integrators, and incumbent platforms that can monetize quantum-adjacent workloads before fault-tolerant systems arrive.

IBM is the cleaner expression of this theme because quantum is an option on top of a cash-generating base, not the investment thesis itself. The second-order effect is valuation asymmetry: profitable incumbents can absorb long-duration R&D while retaining the ability to repurchase shares or fund M&A, whereas the pure plays need recurring equity issuance or debt to survive a multi-year burn. That makes rallies in IONQ/RGTI/QBTS more vulnerable to financing windows closing than to technical setbacks alone.

The bigger contrarian read is that the government investment may actually lengthen the period of speculative overvaluation in the private/early public names by signaling durability to retail flows. But for fundamental investors, that can create a better short setup, not a worse one: if bookings or revenue momentum decelerate even modestly over the next 1-2 quarters, the multiple compression can be abrupt because these names are priced for near-linear adoption. NVDA’s involvement is a reminder that the near-term monetization layer is error correction, tooling, and hybrid computing infrastructure — not the quantum processors themselves.

Key Decisions for Investors

• Long IBM vs. short IONQ in a 3-6 month pair trade: IBM offers quantum exposure with positive cash flow and lower multiple, while IONQ remains highly exposed to any slowdown in contract conversion or capital-market sentiment.
• Avoid initiating new longs in RGTI/QBTS after the policy-driven pop; if you need exposure, use small notional call spreads 6-9 months out to limit downside from secondary offerings or guidance resets.
• Add NVDA on any weakness as a picks-and-shovels beneficiary: the trade is not quantum monetization, but the ecosystem spend on tooling, simulation, and error-correction workflows over the next 12-24 months.
• For hedged exposure, pair long IBM / short a basket of IONQ + RGTI + QBTS equal-weighted; this captures sector enthusiasm while neutralizing the broad ‘quantum wins’ narrative and isolates quality dispersion.
• If IONQ or RGTI rallies another 15-20% without a corresponding step-up in bookings, consider tactical shorts or put spreads into the next quarterly print; the risk/reward improves sharply when enterprise adoption remains story-driven rather than revenue-driven.